Press Release

Menopausal Hot Flashes Market Trending Technologies, Development Plans and Future Growth Forecast 2027

The surge in geriatric women population is expected to stimulate the growth of the market, states Fortune Business Insights, in a report, titled “Menopausal Hot Flashes Market Size, Share & Industry Analysis, By Treatment Type (Hormonal Treatment {Estrogen, Progesterone, Estrogen-progesterone Combination},Non-hormonal Treatment, {Antidepressants, Others}, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026.” The growing awareness regarding women’s health is expected to spur lucrative business opportunities for the market.

The entire world is fighting with the highly contagious coronavirus, which hasdisrupted many industries across the globe. The authorities of several countries have initiated lockdown to prevent the spread of this deadly virus. Such plans have caused disturbances in the production and supply chain. But, with time and resolution, we will be able to combat this stern time and get back to normality. Our well-revised reports will help companies to receive in-depth information about the present scenario of every market so that you can adopt the necessary strategies accordingly.

To get to know more about the short-term and long-term impacts of COVID-19 on this market, please visit:

The menopausal hot flashes marketaccentuates:

  • Comprehensivestudy of the market
  • Present and future forecast
  • In-depthdataabout key players
  • Latest industry trends and drivers

Request a Sample PDF of the Research Report

Market Driver:

Emergence of New treatments to Spur Business Opportunities

The growing prevalence of menopausal hot flashes is likely to encourage the healthy growth of the market during the forecast period. Hot flashes are one of the most common symptoms experienced by women during the time of menopause.According to an article published by the National Center for Biotechnology Information (NCBI), it is estimated that about 1.2 billion women worldwide will be menopausal or post-menopausal by the year 2030. The growing elderly women population is expected to favor the healthy growth of the market. The ongoing development of therapies and treatment by key players is predicted to enable the growth of the market. For instance, in October 2017, Otsuka Pharmaceutical Co., Ltd., announced the launch of EQUELLE, a dietary supplement for the treatment of hot flashes during menopause. The increasing awareness about women’s health through initiatives by various public and private organizations is expected to create lucrative business opportunities for the market in the forthcoming years. However, the side effects associated with hormonal products are expected to be a major factor in diminishing the growth of the market.

Regional Analysis:

Increasing Geriatric Women Population to Promote Growth in North America

The market in North America is expected to experience a rapid growth rate during the forecast period owing to the growing geriatricwomen population with menopausal symptoms in the US and Canada. The growing demand for medical assistance during hot flashes is expected to aid the expansion of the market. According to an article published by the National Center for Biotechnology Information (NCBI), it is estimated that about 85% of post-menopausal women have experienced menopause-related symptoms (hot flashes). Asia Pacific is expected to grow exponentially during the forecast period owing to the rising incidence of menopause in women. Europe is expected to dominate the market during the forecast period due to the development of innovative products by eminent players. The increasing partnership activitiesamong industry players is predicted to foster healthy growth of the market in the region. The surge in elderly women population is predicted to drive the global market in the forthcoming years.

Important Development:

April 2019: TherapeuticsMD, Inc. announced that it has introduced Bijuva (estradiol and progesterone) capsules for the treatment of moderate to severe hot flashes in menopause

The Report Lists the Main Companies in the Menopausal Hot Flashes Market:

  • Pfizer Inc
  • Allergan
  • Teva Pharmaceutical Industries Ltd
  • Mylan N.V
  • Hisamitsu Pharmaceutical Co. Inc.
  • GlaxoSmithKline plc
  • Novo Nordisk A/S

Incase of any queries, speak to our Industry Experts

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.



Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *